SCG
- 产品代码
- SCG
- 器械名称
- Modified Version Of Another ManufacturerS Fda-Authorized Test Within Scope Described In Preamble To Ldt Final Rule
- 管理类别
- 第 N 类(Not Classified)
- FDA 专业组
- Unknown
- 上市路径
- Enforcement Discretion
FDA 分类定义
When a laboratory certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and meeting CLIAs regulatory requirements to perform high complexity testing modifies another manufacturers 510(k) cleared or De Novo authorized test, and in compliance as described in section V.C.3 of the preamble to the LDT Final Rule, in a manner that could not significantly affect the safety or effectiveness of the test and does not constitute a major change or modification in intended use, and where the modified test is performed only in the laboratory making the modification as described in sections V.C.4 and V.C.5 of the preamble to the LDT Final Rule (89 FR 37286).
FDA 官方分类页: SCG
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。